IDH3A and central nervous system cancer: Isocitrate dehydrogenase (IDH)-wildtype gliomas (gliomas that do not have mutations in the IDH genes), resembling glioblastomas, exhibit worse prognoses compared to diffuse IDH-mutated gliomas (IDH mutation confirmed on IHC), characteristic of lower-grade astrocytomas and oligodendrogliomas.